Condition
Merkel Cell Carcinoma of Skin
Total Trials
4
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (2)
Trial Status
Recruiting3
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06014086Phase 1Active Not Recruiting
Intratumoral PH-762 for Cutaneous Carcinoma
NCT06608511Recruiting
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
NCT06780475RecruitingPrimary
Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma
NCT06444815Phase 1Recruiting
A Study of VET3-TGI in Patients With Solid Tumors
Showing all 4 trials